Ultraviolet irradiation increases serum 1,25-dihydroxyvitamin D in vitamin-D-replete adults. 1984

E B Mawer, and J L Berry, and E Sommer-Tsilenis, and W Beykirch, and A Kuhlwein, and B T Rohde

The production of vitamin D metabolites in response to ultraviolet irradiation has been studied in 5 control subjects and 8 patients with psoriasis; both groups responded similarly. Significant increases within the normal range were observed for serum 1,25-dihydroxyvitamin D; these increases were negatively related to the initial concentrations of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D. Serum 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D increased linearly over the 21 days of study, the production of 25-hydroxyvitamin D being negatively correlated with its own initial concentration. The changes in vitamin D metabolism were accompanied by significant rises within the normal ranges in serum inorganic phosphorus and in urinary calcium. These results indicate the variation of 1,25-dihydroxyvitamin D occurs in vitamin-D-replete adults and that this variation is probably responsible for the observed alterations in calcium and phosphorus metabolism.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010758 Phosphorus A non-metal element that has the atomic symbol P, atomic number 15, and atomic weight 31. It is an essential element that takes part in a broad variety of biochemical reactions. Black Phosphorus,Phosphorus-31,Red Phosphorus,White Phosphorus,Yellow Phosphorus,Phosphorus 31,Phosphorus, Black,Phosphorus, Red,Phosphorus, White,Phosphorus, Yellow
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D002112 Calcifediol The major circulating metabolite of VITAMIN D3. It is produced in the LIVER and is the best indicator of the body's vitamin D stores. It is effective in the treatment of RICKETS and OSTEOMALACIA, both in azotemic and non-azotemic patients. Calcifediol also has mineralizing properties. 25-Hydroxycholecalciferol,25-Hydroxyvitamin D 3,25-Hydroxycholecalciferol Monohydrate,25-Hydroxyvitamin D3,Calcidiol,Calcifediol Anhydrous,Calcifediol, (3 alpha,5Z,7E)-Isomer,Calcifediol, (3 beta,5E,7E)-Isomer,Calderol,Dedrogyl,Hidroferol,25 Hydroxycholecalciferol,25 Hydroxycholecalciferol Monohydrate,25 Hydroxyvitamin D 3,25 Hydroxyvitamin D3,Anhydrous, Calcifediol,Monohydrate, 25-Hydroxycholecalciferol
D004100 Dihydroxycholecalciferols Cholecalciferols substituted with two hydroxy groups in any position. Dihydroxyvitamins D
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014467 Ultraviolet Therapy The use of ultraviolet electromagnetic radiation in the treatment of disease, usually of the skin. This is the part of the sun's spectrum that causes sunburn and tanning. Ultraviolet A, used in PUVA, is closer to visible light and less damaging than Ultraviolet B, which is ionizing. Actinotherapy,Therapy, Ultraviolet,Actinotherapies,Therapies, Ultraviolet,Ultraviolet Therapies
D014807 Vitamin D A vitamin that includes both CHOLECALCIFEROLS and ERGOCALCIFEROLS, which have the common effect of preventing or curing RICKETS in animals. It can also be viewed as a hormone since it can be formed in SKIN by action of ULTRAVIOLET RAYS upon the precursors, 7-dehydrocholesterol and ERGOSTEROL, and acts on VITAMIN D RECEPTORS to regulate CALCIUM in opposition to PARATHYROID HORMONE.

Related Publications

E B Mawer, and J L Berry, and E Sommer-Tsilenis, and W Beykirch, and A Kuhlwein, and B T Rohde
January 1981, Calcified tissue international,
E B Mawer, and J L Berry, and E Sommer-Tsilenis, and W Beykirch, and A Kuhlwein, and B T Rohde
April 1995, Annals of internal medicine,
E B Mawer, and J L Berry, and E Sommer-Tsilenis, and W Beykirch, and A Kuhlwein, and B T Rohde
February 1980, American journal of diseases of children (1960),
E B Mawer, and J L Berry, and E Sommer-Tsilenis, and W Beykirch, and A Kuhlwein, and B T Rohde
June 2012, Clinical biochemistry,
E B Mawer, and J L Berry, and E Sommer-Tsilenis, and W Beykirch, and A Kuhlwein, and B T Rohde
March 1982, Ugeskrift for laeger,
E B Mawer, and J L Berry, and E Sommer-Tsilenis, and W Beykirch, and A Kuhlwein, and B T Rohde
February 1979, The New England journal of medicine,
E B Mawer, and J L Berry, and E Sommer-Tsilenis, and W Beykirch, and A Kuhlwein, and B T Rohde
July 1982, Calcified tissue international,
E B Mawer, and J L Berry, and E Sommer-Tsilenis, and W Beykirch, and A Kuhlwein, and B T Rohde
October 1988, BMJ (Clinical research ed.),
E B Mawer, and J L Berry, and E Sommer-Tsilenis, and W Beykirch, and A Kuhlwein, and B T Rohde
September 1983, The Journal of pediatrics,
E B Mawer, and J L Berry, and E Sommer-Tsilenis, and W Beykirch, and A Kuhlwein, and B T Rohde
April 1981, Biochemical and biophysical research communications,
Copied contents to your clipboard!